{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:11:54Z","timestamp":1789729914083,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jvir.2013.01.003","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T01:17:23Z","timestamp":1362705443000},"page":"490-500","source":"Crossref","is-referenced-by-count":66,"title":["Prospective Study of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: An Asian Cooperative Study between Japan and Korea"],"prefix":"10.1016","volume":"24","author":[{"given":"Masafumi","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Anai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hwan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Okusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2013.01.003_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jjco\/hyq169","article-title":"The Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project","volume":"41","author":"Matsuda","year":"2011","journal-title":"Jpn J Clinl Oncol"},{"key":"10.1016\/j.jvir.2013.01.003_bib2","first-page":"676","volume":"37","author":"Ikai","year":"2007","journal-title":"Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. The Liver Cancer Study Group of Japan. Hepatol Res"},{"key":"10.1016\/j.jvir.2013.01.003_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000327577","article-title":"Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version","volume":"29","author":"Kudo","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.jvir.2013.01.003_bib4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2013.01.003_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3348\/kjr.2009.10.5.425","article-title":"The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma","volume":"10","author":"Shin","year":"2009","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jvir.2013.01.003_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0016-5085(88)90436-2","article-title":"Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma\u2014a randomized controlled trial","volume":"94","author":"Lin","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2013.01.003_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0168-8278(90)90110-D","article-title":"A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"11","author":"Pelletier","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2013.01.003_bib8","first-page":"1294","article-title":"A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma","volume":"332","author":"Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2013.01.003_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","article-title":"Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial","volume":"29","author":"Pelletier","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2013.01.003_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep.510270617","article-title":"Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized controlled trial in a single institution","volume":"27","author":"Bruix","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2013.01.003_bib11","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2013.01.003_bib12","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2013.01.003_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejca.2008.01.004","article-title":"Multicentre randomised phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive 9402)","volume":"44","author":"Doffo\u00ebl","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2013.01.003_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials","volume":"224","author":"Camm\u00e0","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2013.01.003_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"issue":"2 suppl 6","key":"10.1016\/j.jvir.2013.01.003_bib16","first-page":"S6","article-title":"Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study)","volume":"24","author":"Kawai","year":"1997","journal-title":"The Cooperative Study Group for Liver Cancer Treatment of Japan. Semin Oncol"},{"key":"10.1016\/j.jvir.2013.01.003_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1148\/radiology.148.2.6306721","article-title":"Hepatic artery embolization in 120 patients with unresectable hepatoma","volume":"148","author":"Yamada","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2013.01.003_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.170.3.2536946","article-title":"Transcatheter oily chemoembolization of hepatocellular carcinoma","volume":"170","author":"Nakamura","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2013.01.003_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF02575465","article-title":"Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma","volume":"13","author":"Uchida","year":"1990","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2013.01.003_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jvir.2013.01.003_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jvir.2006.12.004","article-title":"Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil","volume":"18","author":"Miyayama","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2013.01.003_bib22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3348\/kjr.2008.9.6.534","article-title":"Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization","volume":"9","author":"Ji","year":"2008","journal-title":"Korean J Radiol"},{"issue":"suppl","key":"10.1016\/j.jvir.2013.01.003_bib23","article-title":"A randomized phase II trial of a drug eluting bead in the treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization [abstract 4598]. J Clin Oncol","author":"Lencioni","year":"2008","journal-title":"26"},{"key":"10.1016\/j.jvir.2013.01.003_bib24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000329602","article-title":"A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma","volume":"34","author":"van Malenstein","year":"2011","journal-title":"Onkologie"},{"key":"10.1016\/j.jvir.2013.01.003_bib25","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ejca.2011.05.007","article-title":"Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma","volume":"47","author":"Kudo","year":"2011","journal-title":"Eur J Cancer"},{"issue":"suppl 4","key":"10.1016\/j.jvir.2013.01.003_bib26","article-title":"Sorafenib or placebo in combination with transarterial chemoembolization with doxorubicin-eluting beads for intermediate-stage hepatocellular carcinoma: phase II, randomized, double-blind SPACE trial [abstract LBA154]","volume":"30","author":"Lencioni","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044313000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044313000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T05:57:25Z","timestamp":1539842245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044313000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1051044313000134"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2013.01.003","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}